[1]EuropeanJournalofMedicinalChemistry,2012,vol.54,p.352-365
102082-89-3
147700-58-1
166883-00-7
20595-30-6
18944-77-9
207981-48-4
3005-68-3 | 3-Phenylpyrrolidine-2-carboxylic acid | AA0037M2 | MFCD01191420
37687-57-3 | 2-Chloro-3-hydroxy-4-methoxybenzaldehyde | AA003GSU | MFCD03425852
4142-98-7 | Ethyl 3,5-dihydroxybenzoate | AA003Q3X | MFCD01744651
885965-14-0 | (2'-Methoxy-[1,1'-biphenyl]-4-yl)methanol | AA004AOI | MFCD06802876
6925-69-5 | 4-methyl-1-oxaspiro(5.5)undecene | AA006AD3 | MFCD01791730
1117-74-4 | 4-Oxohexanoic acid | AA007S5E | MFCD00068854
102805-45-8 | [D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT | AA008RPQ | MFCD00133956
13494-90-1 | GALLIUM NITRATE | AA009AS1 | MFCD00011016
1427413-65-7 | 5-Bromo-2-fluorophenacyl bromide | AA009YP6 | MFCD23711739
22868-26-4 | (4-METHOXYPHENYL)DIMETHYLSILANOL | AA00BC6P | MFCD08276887